What is it about?
Men with type 2 diabetes using a medication called SGLT2 inhibitors had a higher risk of developing phimosis (a condition where the foreskin can't be fully retracted) compared to men using another type of diabetes medication called GLP-1 receptor agonists.
Featured Image
Read the Original
This page is a summary of: Risk of Phimosis Associated With SGLT2i Versus GLP-1RA: A Danish Cohort Study, Diabetes Care, July 2025, American Diabetes Association,
DOI: 10.2337/dc25-0693.
You can read the full text:
Contributors
The following have contributed to this page
